Paper20049932
A prospective study of a long-term follow-up of an observation program for neuroblastoma detected by mass screening.
Tanaka M and 7 others. Pediatr Blood Cancer, 2010. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. A prospective study of a long-term follow-up of an observation program for neuroblastoma detected by mass screening. Papers, record 20049932. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20049932
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A prospective study of a long-term follow-up of an observation program for neuroblastoma detected by mass screening.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Mass Screening | Major topic |
| Neoplasm Regression, Spontaneous | Major topic |
| Neuroblastoma | Major topic |
| Antineoplastic Agents | |
| Combined Modality Therapy | |
| Disease Progression | |
| Female | |
| Follow-Up Studies | |
| Homovanillic Acid | |
| Humans | |
| Infant | |
| Male | |
| Neoplasm Staging | |
| Neurosurgical Procedures |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35131881 | Genetic Analysis in African American Children Supports Ancestry-Specific Neuroblastoma Susceptibility. | Cancer Epidemiol Biomarkers Prev | 2022 | https://conductscience.org/library/papers/35131881 | PubMed |
| 31554817 | Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas. | Nat Commun | 2019 | https://conductscience.org/library/papers/31554817 | PubMed |
| 28066990 | Management of adrenal masses in patients with Beckwith-Wiedemann syndrome. | Pediatr Blood Cancer | 2017 | https://conductscience.org/library/papers/28066990 | PubMed |
| 25663695 | Conceptualizing overdiagnosis in cancer screening. | J Natl Cancer Inst | 2015 | https://conductscience.org/library/papers/25663695 | PubMed |
| 25154816 | Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project. | J Clin Oncol | 2014 | https://conductscience.org/library/papers/25154816 | PubMed |
| 23243203 | Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival. | J Natl Cancer Inst | 2013 | https://conductscience.org/library/papers/23243203 | PubMed |
| 22964741 | A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study. | Ann Surg | 2012 | https://conductscience.org/library/papers/22964741 | PubMed |
| 22383024 | Successful treatment of infants with localized neuroblastoma based on their MYCN status. | Int J Clin Oncol | 2013 | https://conductscience.org/library/papers/22383024 | PubMed |
| 21098321 | Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21098321 | PubMed |
| 20957374 | Neonatal tumours. | Pediatr Surg Int | 2010 | https://conductscience.org/library/papers/20957374 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20049932
GET https://conductscience.org/api/papers/v1/20049932/authors